FDA Inspection
Charles River Laboratories IncCharles River Laboratories Inc – FDA Inspection, Feb 7, 2025
Record Details
This FDA Inspection record concerns Charles River Laboratories Inc, with an inspection on February 7, 2025, issued by the New Orleans District Office, covering biologics.
View Company Profile
ID · a3efc927-fe52-4ed6-9694-4526464c95fa
Inspection Facts
- Inspection number
- 1260289
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
5- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.184(c)Individual inventory record
- 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.58Buildings not maintained in good state of repair
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Charles River Laboratories Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 17, 2025 | Not classified | New Orleans District Office | |
| October 11, 2024 | Not classified | New Orleans District Office | |
| November 17, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 25, 2023 | Not classified | New Orleans District Office | |
| January 23, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Charles River Laboratories Inc
- FDA Inspection 1294508 - 2025-10-17
- FDA Inspection 1258366 - 2024-10-11
- FDA Inspection 1224863 - 2023-11-17
- FDA Inspection 1223136 - 2023-08-25
- FDA Inspection 911880 - 2015-01-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.